Hippocampal N-methyl-D-aspartate and kainate binding in response to entorhinal cortex aspiration or 192 IgG-saporin lesions of the basal forebrain.
Lesion models in the rat were used to examine the effects of removing innervation of the hippocampal formation on glutamate receptor binding in that system. Bilateral aspiration of the entorhinal cortex was used to remove the cortical innervation of the hippocampal formation and the dentate gyrus. The subcortical input to the hippocampus from cholinergic neurons of the basal forebrain was lesioned by microinjection of the immunotoxin 192 IgG-saporin into the medial septum and vertical limb of diagonal band. After a 30-day postlesion survival, the effects of these lesions on N-methyl-D-aspartate-displaceable [3H]glutamate and [3H]kainate binding in the hippocampus were quantified using in vitro autoradiography. The bilateral entorhinal lesion induced a sprouting response in the dentate gyrus, measured by an increase in the width of [3H]kainate binding. It also induced an increase in the density of [3H]kainate binding in CA3 stratum lucidum and an increase in N-methyl-D-aspartate binding throughout the hippocampus proper and the dentate gyrus. The selective lesion of cholinergic septal input did not have any effect on hippocampal [3H]kainate binding and induced only a moderate decrease in N-methyl-D-aspartate binding that was not statistically reliable. The entorhinal and cholinergic lesions were used as in vivo models of the degeneration of hippocampal input that occurs in normal aging and Alzheimer's disease. The results from the present lesion study suggest that some, but not all, of the effects on hippocampal [3H]kainate and N-methyl-D-aspartate binding induced by the lesions are consistent with the status of binding to these receptors in aging and Alzheimer's disease. Consistent with the effects of aging and Alzheimer's disease is an altered topography of [3H]kainate binding after entorhinal cortex lesion and a modest decline in N-methyl-D-aspartate binding after lesions of the cholinergic septal input to the hippocampus.
Nicolle
M M
MM
Curriculum in Neurobiology, University of North Carolina, Chapel Hill, U.S.A.
Shivers
A
A
Gill
T M
TM
Gallagher
M
M
D000110:Acetylcholinesterase / Q000378:metabolism; D000375:Aging / Q000378:metabolism; D000818:Animals; D000911:Antibodies, Monoclonal / Q000633:toxicity; D018678:Cholinergic Agents / Q000633:toxicity; D018728:Entorhinal Cortex / Q000187:drug effects / Q000473:pathology / Q000502:physiology*; D018698:Glutamic Acid / Q000378:metabolism; D006624:Hippocampus / Q000254:growth & development / Q000378:metabolism*; D000922:Immunotoxins / Q000633:toxicity; D007608:Kainic Acid / Q000378:metabolism*; D007700:Kinetics; D008297:Male; D009699:N-Glycosyl Hydrolases; D016202:N-Methylaspartate / Q000378:metabolism*; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D016548:Prosencephalon / Q000473:pathology / Q000502:physiology; D011712:Pyramidal Tracts / Q000187:drug effects / Q000502:physiology; D011869:Radioligand Assay; D051381:Rats; D017470:Receptors, Glutamate / Q000378:metabolism*; D018092:Kainic Acid Receptors / Q000378:metabolism*; D016194:Receptors, N-Methyl-D-Aspartate / Q000378:metabolism*; D054789:Ribosome Inactivating Proteins, Type 1; D000076985:Saporins; D014316:Tritium
D000110:Acetylcholinesterase; D000911:Antibodies, Monoclonal; D018678:Cholinergic Agents; D018698:Glutamic Acid; D000922:Immunotoxins; D007608:Kainic Acid; D009699:N-Glycosyl Hydrolases; D016202:N-Methylaspartate; D017470:Receptors, Glutamate; D018092:Kainic Acid Receptors; D016194:Receptors, N-Methyl-D-Aspartate; D054789:Ribosome Inactivating Proteins, Type 1; D000076985:Saporins; D014316:Tritium; C085696:192 IgG-saporin